Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemic
M Puopolo, C Morciano, M Buoncervello, C De Nuccio… - Trials, 2022 - Springer
… an 11-month period between May 2020 and April 2021, we performed a survey of the Italian
COVID-19 clinical trials on therapeutic and prophylactic drugs and convalescent plasma. …
COVID-19 clinical trials on therapeutic and prophylactic drugs and convalescent plasma. …
SARS-CoV-2 neutralizing antibody titers in convalescent plasma and recipients in New Mexico: an open treatment study in COVID-19 patients
…, I Hurwitz, AV Yingling, C Ye… - The Journal of …, 2020 - pmc.ncbi.nlm.nih.gov
… acute COVID-19 patients remains largely undetermined. We measured NAb titers in CP and
in acute COVID-19 … TN, NS, and MH performed the clinical studies and collected the patient …
in acute COVID-19 … TN, NS, and MH performed the clinical studies and collected the patient …
Efficacy and harms of convalescent plasma for treatment of hospitalized COVID-19 patients: a systematic review and meta-analysis
A Piscoya, LF Ng-Sueng, AP Del Riego… - Archives of Medical …, 2021 - pmc.ncbi.nlm.nih.gov
… studies assessing CP effects on hospitalized, adult COVID-19 patients were searched until
November 24, 2020. We … , 1 pre-print website, and 3 clinical trial registries. Second, our study …
November 24, 2020. We … , 1 pre-print website, and 3 clinical trial registries. Second, our study …
[PDF][PDF] Who is making clinical trials for treatment or prevention of COVID-19? A review of Clinicaltrials. gov, May 2020.
M Fors, P González - F1000Research, 2020 - academia.edu
… , while 10.2% are studying the use of convalescent plasma to treat the … number of
COVID-19-related clinical trials. There are challenges in conducting clinical research on COVID-19, …
COVID-19-related clinical trials. There are challenges in conducting clinical research on COVID-19, …
Review of registered clinical trials for the treatment of COVID‐19
… Convalescent plasma therapy from recovered patients is … to now, some studies have reported
that convalescent plasma … a clinical trial in severe COVID-19 infection (Davies et al., 2020). …
that convalescent plasma … a clinical trial in severe COVID-19 infection (Davies et al., 2020). …
Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19
… Clinical studies have identified a cytokine storm in the third … By September 9, 2020 the
number of deaths raised to 896K … Several biological agents like convalescent plasma, neutralize …
number of deaths raised to 896K … Several biological agents like convalescent plasma, neutralize …
'Convalescent Plasma'-An Effective Treatment Option to Prevent Emerging nCOVID-19-A Review
S Ashique, T Khatun, G Sahu… - Infectious Disorders …, 2022 - benthamdirect.com
… Concerning systematized data till the first July 2020, just two … randomized convalescent
plasma therapy clinical trial was … of action of convalescent plasma in severe COVID-19 patients. …
plasma therapy clinical trial was … of action of convalescent plasma in severe COVID-19 patients. …
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience
TN Glatt, C Hilton, C Nyoni, A Swarts, R Swanevelder… - Viruses, 2021 - mdpi.com
… clinical trial of the Therapeutic use of convalEsCenT plasma in the treatment of patients with
moderate to severe COVID-19) … in April 2020, and collections started on the 1 May 2020. The …
moderate to severe COVID-19) … in April 2020, and collections started on the 1 May 2020. The …
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
M Desmarets, S Hoffmann, C Vauchy, BJA Rijnders… - BMJ open, 2023 - bmjopen.bmj.com
… Besides, most of these trials were initiated in spring 2020 when availability and information
… common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020:e192–7…
… common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020:e192–7…
Convalescent Plasma in treatment of COVID-19: A review of evidence for a living systematic benefit-risk assessment
M Davies, S Lane, A Evans, J Denyer, S Dhanda… - medRxiv, 2020 - medrxiv.org
… endpoints) were derived from both published literature and in the case of ongoing studies,
available clinical trial protocols. These benefits and risks, as presented in the value tree, were …
available clinical trial protocols. These benefits and risks, as presented in the value tree, were …